… In conclusion, cationic nanostructured lipid carriers may be an … of lipid-based quercetin
nanoliposomes in rats [17]. … , the biodistribution of those carriers in vivo have not been described. …

We aimed to evaluate whether the enhancement of the liver accumulation and anti-inflammatory
activity of dexamethasone acetate (DXMA) could be achieved by incorporating it into …

… One crucial point about the in vivo use of nanoparticles and in particular of NLC is the
study of their in vivo biodistribution. In spite of a large amount of knowledge about the …

… In the present study, the in vivo biodistribution of NLC in an ApoE -/- atherosclerotic mice …
from RXP470.1 showed excellent in vivo performances of targeting MMP12 within carotid …

… In vivo biodistribution studies The in vivo biodistribution studies were carried out for …
The biodistribution study was carried out on the Balb/c mice (aged 6–8 weeks) weighing …

… solid-lipids and liquid-lipids which could … lipid carriers with targeting and prolonged release
properties for intravenous delivery of silybin and evaluate its characteristics in vitro and in vivo…

… Therefore, the aim of this work was to evaluate the in vivo properties of a Tc-99m-labeled
nanostructured lipid carrier (NLC) formulation, co-loaded with doxorubicin (DOX) and …

… The independent factors were lipid amount (X 1 ), surfactant amount … In vivo biodistribution
in mice was evaluated by a … of nano-structured lipid carriers had great potential as an effective …

… The in vivo biodistribution study using Wistar rats demonstrated that SLN could … biodistribution
pattern strongly supports the existence of resveratrol in intact form within the lipid carrier …

… This study provides the pharmacokinetics and biodistribution profile of TQ-NLC in vivo …
This study determined the pharmacokinetics and biodistribution of 99m Tc-TQ-NLC in vivo after …